Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid Sequence Awakeness with remimazolam and flumazenil vs standard emergence in pediatric anesthesia
jRCTs021240059Recruiting
- Start
- Feb 2025
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam and flumazenil (2 arms). Primary endpoint: Incidence of emergence agitation/emergence delirium (EA/ED) up to 15 minutes after awakening and extubation. Started Feb 2025; status: recruiting.
02
Drugs
remimazolamflumazenil
Beyond the preview
Go deeper on jRCTs021240059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021240059.